Table 2.

Summary data for the association between ABO haplotypes and studied traits

ABO blood grouprs2519093rs8176719rs579459rs1053878rs8176743rs41302905Frequency*OR for VTImpact on VWF/FVIII levelsImpact on ICAM1 levels
O1 delG 0.63 Reference Reference Reference 
O2 T 0.02 0.70§ (0.57-0.86) — — 
A1 T 0.20 1.78 (1.67-1.92) ↑↑↑ ↓↓↓ 
A2 A 0.07 1.16 (1.03-1.31) ↑ ↓ 
T 0.08 1.76 (1.58-1.96) ↑↑↑ — 
ABO blood grouprs2519093rs8176719rs579459rs1053878rs8176743rs41302905Frequency*OR for VTImpact on VWF/FVIII levelsImpact on ICAM1 levels
O1 delG 0.63 Reference Reference Reference 
O2 T 0.02 0.70§ (0.57-0.86) — — 
A1 T 0.20 1.78 (1.67-1.92) ↑↑↑ ↓↓↓ 
A2 A 0.07 1.16 (1.03-1.31) ↑ ↓ 
T 0.08 1.76 (1.58-1.96) ↑↑↑ — 

Minor alleles are shown in bold.

—,

no effect of a given haplotype on the studied trait.

*

Haplotype frequencies in European ancestry populations.

Haplotypic risk estimate (95% CI) for VT obtained from the meta-analysis of results listed in supplemental Tables 1-6.

Direction (↑= increase; ↓= decrease) of haplotype effects on plasma levels. Strong vs modest effects are illustrated by 3 arrows vs 1 arrow.

§

This risk estimate exhibited statistical heterogeneity (P = 1.2 × 10−3) across the 6 investigated studies.

or Create an Account

Close Modal
Close Modal